Cardiac resynchronization therapy defibrillator: a <i>de novo</i> implant in a COVID-19 patient by an echo-guided axillary venous approach-Reference-Cited by-全球学者库

Cardiac resynchronization therapy defibrillator: a de novo implant in a COVID-19 patient by an echo-guided axillary venous approach

Published:2022-08 Issue:8 Volume:18 Page:621-626
ISSN:1479-6678
Container-title:Future Cardiology
language:en
Short-container-title:Future Cardiology

Author:

Agea Aldo¹^ORCID,Bellino Maria C¹,Gianfrancesco Domenico²,Palma Francesco¹,Carpagnano Giuseppe A¹,Torraco Rita MR¹,Marino Maria M¹,Persichella Paola¹,Zingaro Sebastiano¹,Siena Fabio¹,Di Tullio Roberto¹,Deluca Giovanni¹

Affiliation:

1. Monsignor Dimiccoli Hospital, Cardiology, Barletta, Puglia, 76121, Italy

2. Ospedale Lorenzo Bonomo, Cardiology, Andria, Puglia, 76123, Italy

Abstract

The COVID-19 pandemic has seriously revolutionized the management of patients who need an implanted cardiac implantable electronic device. We report, for the first time, a successful cardiac resynchronization therapy defibrillator implantation procedure in an 82-year-old man affected by COVID-19, recent myocardial infarction, second-degree 2:1 atrioventricular block and left bundle branch block.

Publisher

Future Medicine Ltd

Subject

Cardiology and Cardiovascular Medicine,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fca-2021-0055

Reference15 articles.

1. Clinical manifestation and disease progression in COVID-19 infection

2. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)

3. Ultrasound‐guided venipuncture for implantation of cardiac implantable electronic devices: A single‐center, retrospective study

4. European Society for Cardiology. ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic (2020). www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance